Home / CHF / Vifor Pharma Group Reports Continued Growth in H1 2020

Vifor Pharma Group Reports Continued Growth in H1 2020

Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic.
Read Full Story at source (may require registration)